New gene therapy combo aims to keep advanced lung cancer in check

NCT ID NCT05703971

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new gene therapy (quaratusugene ozeplasmid) plus an immunotherapy drug (atezolizumab) as maintenance treatment for people with extensive stage small cell lung cancer. The goal is to see if the combination can keep the cancer from growing longer than standard care. About 62 adults who have already responded to initial chemo-immunotherapy will take part. The trial has two phases: first finding the best dose, then checking safety and effectiveness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER EXTENSIVE STAGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Gabrail Cancer Center Research

    RECRUITING

    Canton, Ohio, 44718, United States

  • Northwest Cancer Specialists, P.C.

    RECRUITING

    Portland, Oregon, 97213-2982, United States

  • Northwest Cancer Specialists, P.C.

    RECRUITING

    Portland, Oregon, 97227, United States

  • Northwest Cancer Specialists, P.C.

    RECRUITING

    Tigard, Oregon, 97223, United States

  • Northwest Cancer Specialists, P.C.

    TERMINATED

    Vancouver, Washington, 98684, United States

  • Oncology_Hematology Care Clinical Trials, LLC

    RECRUITING

    Cincinnati, Ohio, 45211, United States

  • Oncology_Hematology Care Clinical Trials, LLC

    RECRUITING

    Cincinnati, Ohio, 45236, United States

  • Oncology_Hematology Care Clinical Trials, LLC

    RECRUITING

    Cincinnati, Ohio, 45242, United States

  • Oncology_Hematology Care Clinical Trials, LLC

    RECRUITING

    Cincinnati, Ohio, 45245, United States

  • Oncology_Hematology Care Clinical Trials, LLC

    RECRUITING

    Fairfield, Ohio, 45014, United States

  • Providence Cancer Institute

    RECRUITING

    Portland, Oregon, 97213, United States

    Contact Email: •••••@•••••

  • Rocky Mountain Cancer Centers, LLP

    RECRUITING

    Lone Tree, Colorado, 80124, United States

  • Texas Oncology - DFW

    RECRUITING

    Dallas, Texas, 75246, United States

  • Texas Oncology - Northeast Texas

    RECRUITING

    Tyler, Texas, 75702, United States

  • Virginia Cancer Specialists, PC

    RECRUITING

    Fairfax, Virginia, 22031, United States

  • Washington University School of Medicine - Siteman Cancer Center

    RECRUITING

    St Louis, Missouri, 63110, United States

  • Willamette Valley Cancer Institute (Oregon)

    RECRUITING

    Eugene, Oregon, 97401, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.